A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States.
Health & Medicine
A study on the anticonvulsant drug topiramate led by Henry Kranzler of the Perelman School of Medicine is highlighted.
Whether it is playing a piano sonata or acing a tennis serve, the brain needs to orchestrate precise, coordinated control over the body’s many muscles. Moreover, there needs to be some kind of feedback from the senses should any of those movements go wrong.
Penn Study: Blocking Autophagy with Malaria Drug May Help Overcome Resistance to BRAF Drugs in Melanoma
Half of melanoma patients with the BRAF mutation have a positive response to treatment with BRAF inhibitors, but nearly all of those patients develop resistance to the drugs and experience disease progression.
An international team of scientists has traced the origin of Plasmodium vivax, the second-worst malaria parasite of humans, to Africa, according to a study published this week in Nature Communications.
Adult stem cells and cancer cells have many things in common, including an ability to migrate through tiny gaps in tissue. Both types of cells also experience a trade-off when it comes to this ability; having a flexible nucleus makes migration easier but is worse at protecting the nucleus’ DNA compared to a stiffer nucleus.
A newly developed, more specific approach to classifying tumors by molecular type can help cancer researchers to determine tumor characteristics and guide treatment strategies.
Michael Blank and Dwight Evans of the Perelman School of Medicine discuss researching mental health patients’ likelihood of contracting HIV.
M. Kit Delgado of the Perelman School of Medicine is featured for authoring a new study on patients that go to trauma centers.
H. Lee Sweeney of the Perelman School of Medicine says, “The world may be about to watch one of its last Olympic Games without genetically enhanced athletes.”